Those "scientists at the Baker IDI Heart and Diabetes Institute to employ Seahorse Extracellular Flux (XFÓ) microassay technology to assess the effect of novel Prana drugs " should have completed their assessment by now, don't you think? This mention by Prana in LAST YEAR's AGM has not been followed by a P.R. or any communication to inform the public about "the effect of novel Prana drugs".
What can the public think of this situation except that results were not positive. If results were positive, there is no evidence that Prana has acted upon them. Judging from past history, it's not likely that the subject will be addressed again in the next AGM.
New strategy ?, page-7
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.96M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.3¢ | 0.3¢ | $3.631K | 1.210M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 60 | 81072032 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 2447647 | 3 |
View Market Depth
| Last trade - 15.59pm 18/09/2024 (20 minute delay) ? |
| ATH (ASX) Chart |